The methodology of TSPO imaging with positron emission tomography

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 586-592

  Turkheimer, Federico E ^a   Rizzo, Gaia ^b   Bloomfield, Peter S ^c   Howes, Oliver ^a,c   Zanotti Fregonara, Paolo ^d   Bertoldo, Alessandra ^b   Veronese, Mattia ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF PADOVA   (Italy)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Endothelium; Genetics; Heterogeneity; Kinetic modelling; Methodology; Microglia; Neuroinflammation; Peripheral benzodiazepine receptor (PBR); Peripheral benzodiazepine receptor (PBR)28; PK11195; Plasma free fraction; Positron emission tomography; Schizophrenia; Translocator protein (TSPO)

Indexed keywords

N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE C 11; 4 AMINOBUTYRIC ACID RECEPTOR; ISOQUINOLINE DERIVATIVE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; TSPO PROTEIN, HUMAN;

BLOOD BRAIN BARRIER; BRAIN TISSUE; COMORBIDITY; HUMAN; IMAGE QUALITY; IN VIVO STUDY; ISOTOPE LABELING; NERVOUS SYSTEM INFLAMMATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; TRANSLOCATOR PROTEIN POSITRON EMISSION TOMOGRAPHY; BLOOD; DEVICES; DIAGNOSTIC IMAGING; GENETICS; METABOLISM; MICROGLIA; PROCEDURES;

HUMANS; ISOQUINOLINES; MICROGLIA; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, GABA;

EID: 84938796529     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150058     Document Type: Review

References (40)

1. Charbonneau, P., Syrota, A., Crouzel, C., Valois, J.M., Prenant, C. and Crouzel, M. (1986) Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography. Circulation 73, 476-483 CrossRef PubMed
2. Myers, R., Manjil, L.G., Cullen, B.M., Price, G.W., Frackowiak, R.S. and Cremer, J.E. (1991) Macrophage and astrocyte populations in relation to [3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion. J. Cereb. Blood Flow Metab. 11, 314-322 CrossRef PubMed
3. Ramsay, S.C., Weiller, C., Myers, R., Cremer, J.E., Luthra, S.K., Lammertsma, A.A. and Frackowiak, R.S. (1992) Monitoring by PET of macrophage accumulation in brain after ischaemic stroke. Lancet 339, 1054-1055 CrossRef PubMed
4. Banati, R.B., Newcombe, J., Gunn, R.N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D.H. et al. (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 (Pt 11), 2321-2337 CrossRef PubMed
5. Cagnin, A., Brooks, D.J., Kennedy, A.M., Gunn, R.N., Myers, R., Turkheimer, F.E., Jones, T. and Banati, R.B. (2001) In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467 CrossRef PubMed
6. Edison, P., Archer, H.A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F.E., Hammers, A., Tai, Y.F., Fox, N., Kennedy, A. et al. (2008) Microglia, amyloid, and cognition in Alzheimer's disease: an [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol. Dis. 32, 412-419 CrossRef PubMed
7. Gerhard, A., Banati, R.B., Goerres, G.B., Cagnin, A., Myers, R., Gunn, R.N., Turkheimer, F., Good, C.D., Mathias, C.J., Quinn, N. et al. (2003) [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology 61, 686-689 CrossRef PubMed
8. Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R.B. and Brooks, D.J. (2006) In vivo imaging of microglial activation with [11C](R)- PK11195 PET in idiopathic Parkinson's disease. Neurobiol. Dis. 21, 404-412 CrossRef PubMed
9. Gerhard, A., Watts, J., Trender-Gerhard, I., Turkheimer, F., Banati, R.B., Bhatia, K. and Brooks, D.J. (2004) In vivo imaging of microglial activation with [11C](R)-PK11195 PET in corticobasal degeneration. Mov. Disord. 19, 1221-1226 CrossRef PubMed
10. Okello, A., Edison, P., Archer, H.A., Turkheimer, F.E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M. and Brooks, D.J. (2009) Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 72, 56-62 CrossRef PubMed
11. Turner, M.R., Cagnin, A., Turkheimer, F.E., Miller, C.C., Shaw, C.E., Brooks, D.J., Leigh, P.N. and Banati, R.B. (2004) Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol. Dis. 15, 601-609 CrossRef PubMed
12. Pavese, N., Gerhard, A., Tai, Y.F., Ho, A.K., Turkheimer, F., Barker, R.A., Brooks, D.J. and Piccini, P. (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66, 1638-1643 CrossRef PubMed
13. Ramlackhansingh, A.F., Brooks, D.J., Greenwood, R.J., Bose, S.K., Turkheimer, F.E., Kinnunen, K.M., Gentleman, S., Heckemann, R.A., Gunanayagam, K., Gelosa, G. and Sharp, D.J. (2011) Inflammation after trauma: microglial activation and traumatic brain injury. Ann. Neurol. 70, 374-383 CrossRef PubMed
14. Pappata, S., Cornu, P., Samson, Y., Prenant, C., Benavides, J., Scatton, B., Crouzel, C., Hauw, J.J. and Syrota, A. (1991) PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report. J. Nucl. Med. 32, 1608-1610 PubMed
15. Takaya, S., Hashikawa, K., Turkheimer, F.E., Mottram, N., Deprez, M., Ishizu, K., Kawashima, H., Akiyama, H., Fukuyama, H., Banati, R.B. and Roncaroli, F. (2007) The lack of expression of the peripheral benzodiazepine receptor characterises microglial response in anaplastic astrocytomas. J. Neurooncol. 85, 95-103 CrossRef PubMed
16. Jacobs, A.H., Tavitian, B. and consortium, I.N. (2012) Noninvasive molecular imaging of neuroinflammation. J. Cereb. Blood Flow Metab. 32, 1393-1415 CrossRef PubMed
17. Converse, A.K., Larsen, E.C., Engle, J.W., Barnhart, T.E., Nickles, R.J. and Duncan, I.D. (2011) 11C-(R)-PK11195 PET imaging of microglial activation and response to minocycline in zymosan- treated rats. J. Nucl. Med. 52, 257-262 CrossRef PubMed
18. Dodel, R., Spottke, A., Gerhard, A., Reuss, A., Reinecker, S., Schimke, N., Trenkwalder, C., Sixel- Doring, F., Herting, B., Kamm, C. et al. (2010) Minocycline 1-year therapy in multiple- system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial). Mov. Disord. 25, 97-107 CrossRef PubMed
19. Martini, C., Chelli, B., Betti, L., Montali, M., Mancuso, M., Giannaccini, G., Rocchi, A., Murri, L. and Siciliano, G. (2002) Peripheral benzodiazepine binding sites in platelets of patients affected by mitochondrial diseases and large scale mitochondrial DNA rearrangements. Mol. Med. 8, 841-846 PubMed
20. Soreni, N., Apter, A., Weizman, A., Don-Tufeled, O., Leschiner, S., Karp, L. and Gavish, M. (1999) Decreased platelet peripheral-type benzodiazepine receptors in adolescent inpatients with repeated suicide attempts. Biol. Psychiatry 46, 484-488 CrossRef PubMed
21. Pini, S., Martini, C., Abelli, M., Muti, M., Gesi, C., Montali, M., Chelli, B., Lucacchini, A. and Cassano, G.B. (2005) Peripheral-type benzodiazepine receptor binding sites in platelets of patients with panic disorder associated to separation anxiety symptoms. Psychopharmacology 181, 407-411 CrossRef PubMed
22. Begni, B., Tremolizzo, L., Andreoni, S., Contri, M., Uccellini, O., Neri, F. and Ferrarese, C. (2009) Neuroligand binding endophenotypes in blood cells distinguish two subsets of borderline personality disorder patients. Neurosci. Lett. 462, 144-146 CrossRef PubMed
23. Ritsner, M., Modai, I., Gibel, A., Leschiner, S., Silver, H., Tsinovoy, G., Weizman, A. and Gavish, M. (2003) Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients. J. Psychiatr. Res. 37, 549-556 CrossRef PubMed
24. Lockhart, A., Davis, B., Matthews, J.C., Rahmoune, H., Hong, G., Gee, A., Earnshaw, D. and Brown, J. (2003) The peripheral benzodiazepine receptor ligand PK11195 binds with high affinity to the acute phase reactant alpha1-acid glycoprotein: implications for the use of the ligand as a CNS inflammatory marker. Nucl. Med. Biol. 30, 199-206 CrossRef PubMed
25. Turkheimer, F.E., Edison, P., Pavese, N., Roncaroli, F., Anderson, A.N., Hammers, A., Gerhard, A., Hinz, R., Tai, Y.F. and Brooks, D.J. (2007) Reference and target region modeling of [11C]-(R)- PK11195 brain studies. J. Nucl. Med. 48, 158-167 PubMed
26. Yaqub, M., van Berckel, B.N., Schuitemaker, A., Hinz, R., Turkheimer, F.E., Tomasi, G., Lammertsma, A.A. and Boellaard, R. (2012) Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[(11)C]PK11195 brain PET studies. J. Cereb. Blood Flow Metab. 32, 1600-1608 CrossRef PubMed
27. Anderson, A.N., Pavese, N., Edison, P., Tai, Y.F., Hammers, A., Gerhard, A., Brooks, D.J. and Turkheimer, F.E. (2007) A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195. NeuroImage 36, 28-37 CrossRef PubMed
28. Tomasi, G., Edison, P., Bertoldo, A., Roncaroli, F., Singh, P., Gerhard, A., Cobelli, C., Brooks, D.J. and Turkheimer, F.E. (2008) Novel reference region model reveals increased microglial and reduced vascular binding of 11C-(R)-PK11195 in patients with Alzheimer's disease. J. Nucl. Med. 49, 1249-1256 CrossRef PubMed
29. Chauveau, F., Boutin, H., Van Camp, N., Dolle, F. and Tavitian, B. (2008) Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur. J. Nucl. Med. Mol. Imaging 35, 2304-2319 CrossRef PubMed
30. Owen, D.R., Yeo, A.J., Gunn, R.N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D.J., Bennacef, I., Parker, C.A. et al. (2012) An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J. Cereb. Blood Flow Metab. 32, 1-5 CrossRef PubMed
31. Rizzo, G., Veronese, M., Tonietto, M., Zanotti-Fregonara, P., Turkheimer, F.E. and Bertoldo, A. (2014) Kinetic modeling without accounting for the vascular component impairs the quantification of [(11)C]PBR28 brain PET data. J. Cereb. Blood Flow Metab. 34, 1060-1069 CrossRef PubMed
32. Delforge, J., Syrota, A. and Bendriem, B. (1996) Concept of reaction volume in the in vivo ligand- receptor model. J. Nucl. Med. 37, 118-125 PubMed
33. Blank, T. and Prinz, M. (2013) Microglia as modulators of cognition and neuropsychiatric disorders. Glia 61, 62-70 CrossRef PubMed
34. Stefansson, H., Ophoff, R.A., Steinberg, S., Andreassen, O.A., Cichon, S., Rujescu, D., Werge, T., Pietilainen, O.P., Mors, O., Mortensen, P.B. et al. (2009) Common variants conferring risk of schizophrenia. Nature 460, 744-747 PubMed
35. Monji, A., Kato, T. and Kanba, S. (2009) Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin. Neurosci. 63, 257-265 CrossRef PubMed
36. Miyaoka, T., Yasukawa, R., Yasuda, H., Hayashida, M., Inagaki, T. and Horiguchi, J. (2008) Minocycline as adjunctive therapy for schizophrenia: an open-label study. Clin. Neuropharmacol. 31, 287-292 CrossRef PubMed
37. van Berckel, B.N., Bossong, M.G., Boellaard, R., Kloet, R., Schuitemaker, A., Caspers, E., Luurtsema, G., Windhorst, A.D., Cahn, W., Lammertsma, A.A. and Kahn, R.S. (2008) Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol. Psychiatry 64, 820-822 CrossRef PubMed
38. Doorduin, J., de Vries, E.F., Willemsen, A.T., de Groot, J.C., Dierckx, R.A. and Klein, H.C. (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J. Nucl. Med. 50, 1801-1807 CrossRef PubMed
39. Kenk, M., Selvanathan, T., Rao, N., Suridjan, I., Rusjan, P., Remington, G., Meyer, J.H., Wilson, A.A., Houle, S. and Mizrahi, R. (2014) Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr. Bull. 41, 85-93 CrossRef PubMed
40. Bloomfield, P.S.S.S., Veronese, M., Rizzo, G., Bertoldo, A., Owen, D.R., Bloomfield, M.A.P., Bonoldi, I., Kalk, N., Turkheimer, F., McGuire, P. et al. Microglial activity in people at ultra high risk of psychosis and in schizophrenia; an [11C]PBR28 PET brain imaging study. Society of Biological Psychiatry, 70th Annual Meeting, 14-16 May 2015